Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:00:02 21/05/2024 BST 5-day change 1st Jan Change
75.67 USD +0.41% Intraday chart for Boston Scientific Corporation +2.97% +30.89%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CL King Adjusts Price Target on Boston Scientific to $90 From $82 MT
Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating MT
Transcript : Boston Scientific Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing MT
Boston Scientific Corporation Appoints Cheryl Pegus to its Board of Directors CI
Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $719,562, According to a Recent SEC Filing MT
Daiwa Adjusts Price Target on Boston Scientific to $81 From $73 MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75 MT
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength RE
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68 MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75 MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $73 From $63 MT
Baird Adjusts Price Target on Boston Scientific to $84 From $79 MT
JPMorgan Adjusts Price Target on Boston Scientific to $82 From $72 MT
Raymond James Adjusts Boston Scientific Price Target to $85 From $73 MT
Wolfe Research Adjusts Boston Scientific Price Target to $81 From $72 MT
CL King Adjusts Boston Scientific's Price Target to $82 From $72 MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $83 From $81 MT
Barclays Adjusts Boston Scientific's Price Target to $78 From $70 MT
Wells Fargo Adjusts Price Target on Boston Scientific to $82 From $72 MT
Truist Raises Price Target on Boston Scientific to $86 From $79, Keeps Buy Rating MT
Chart Boston Scientific Corporation
More charts
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
75.67 USD
Average target price
81.33 USD
Spread / Average Target
+7.48%
Consensus
  1. Stock Market
  2. Equities
  3. BSX Stock
  4. News Boston Scientific Corporation
  5. Boston Scientific Insider Sold Shares Worth $1,133,069, According to a Recent SEC Filing